JPRN-UMIN000016950
Completed
未知
Clinical outcome in patients with rheumatoid arthritis switched to tumor nesrosis factor blockers after tocilizumab or abatacept - Clinical outcome in patients with RA switched to TNF blocker after tocilizumab or abatacept
Conditionsrheumatoid arthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- rheumatoid arthritis
- Sponsor
- Osaka Medical College
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Outcome of Rheumatoid Arthritits patients following adjunct statin therapyHealth Condition 1: null- Diagnosed Rheumatoid Arthritis patients with active diseaseCTRI/2014/12/005233Kalinga Institute of Medical Sciences60
Completed
Not Applicable
Retention rate of iguratimod with and without methotrexate in patients with rheumatoid arthritis.JPRN-UMIN000041767Department of Hematology and Rheumatology, Kindai University School of Medicine106
Completed
Not Applicable
Follow-up study of patients with rheumatoid arthritis who treated infliximab for 1 year and did not reach a clinical remission in RRRR StudyRheumatoid ArthritisJPRN-UMIN000007539niversity of Occupational and Environmental Health, Japan108
Recruiting
Phase 1
ORBIT studyRheumatoid ArthritisPACTR201208000399382Dr B Hodkinson100
Recruiting
Not Applicable
Efficacy and safety of intra-articular steroid injection for inflamed atlantoaxial joint in patients with rheumatoid arthritisatlantoaxial joint arthritis in rheumatoid patientsInflammatory and Immune System - Rheumatoid arthritisACTRN12616000750482Diab Fuad Hetta60